Prof. Dr. Emre Merdan Fayda

Domaines d’intérêt médical indiqués par le médecin lui-même sur sa page du site de l’établissement. Source : livhospital.com.

Expérience

• ExpérienceLiv Hospital, Radyasyon Onkolojisilivhospital.com
• 2012İstanbul Üniversitesi, Onkoloji Enstitüsü, Doçent Doktorlivhospital.com
• 2010-2011Stereotaktik Radyoterapi, Torasik Onkoloji, University of North Carolina, NC, ABDlivhospital.com
• 2006-2009Kocaeli Üniversitesi, Radyasyon Onkolojisi Anabilim Dalı, Yardımcı Doçentlivhospital.com
• 2004-2005GATA Radyasyon Onkolojisi Anabilim Dalı, Uzman Doktor, Yedek Subaylivhospital.com
• 1999-2004İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Dr.Ar.Gör.livhospital.com

• SpécialitéOncologie-radiothérapielivhospital.comD’après la source
• ÉtablissementLiv Hospital Uluslivhospital.comD’après la source
• Publications53 publicationsOpenAlex, page de profil sur livhospital.comD’après la source
• Dernière synchronisation4 novembre 2026 20:55https://www.livhospital.com/prof-dr-merdan-faydalivhospital.com

1. Clinical distuingishing characteristics and management of phyllodes tumors of the breast.

   Journal of Clinical Oncology, 2015

   DOI 10.1200/jco.2015.33.15_suppl.e12060 Source : OpenAlex

2. Nasopharyngeal carcinoma patients with new primaries.

   Journal of Clinical Oncology, 2014

   DOI 10.1200/jco.2014.32.15_suppl.6087 Source : OpenAlex

3. Turkkan G, Bilici N, Sertel H, Keskus Y, Alkaya S, Tavli B, Ozkirim M, Fayda M. Clinical utility of a 1.5 T magnetic resonance imaging-guided linear accelerator during conventionally fractionated and hypofractionated prostate cancer radiotherapy. Front Oncol. 2022 Aug 16;12:909402.

   Source : page de profil sur livhospital.com

4. Fayda M. Having ypN0 may not be enough to abandon the postmastectomy radiotherapy (PMRT) in Her-2 positive patients. Radiotherapy&Oncology. Published:May 25, 2023. DOI:https://doi.org/10.1016/j.radonc.2023.109722

   Source : page de profil sur livhospital.com

5. Tambas M, Tavli B, Bilici N, Dizman A, Sertel H, Fayda M. Computed Tomography-Guided Optimization of Needle Insertion for Combined Intracavitary/Interstitial Brachytherapy With Utrecht Applicator in Locally Advanced Cervical Cancer. Pract Radiat Oncol. 2021 Feb 5:S1879-8500(21)00043-6. doi: 10.1016/j.prro.2021.01.008. Epub ahead of print. PMID: 33556579.

   Source : page de profil sur livhospital.com

6. Turkkan, G, Bilici N, Sertel H, Tavlı B, Özkırım M, Fayda M. Dosimetric Comparison of Volumetric Modulated Arc Therapy and Dynamic Conformal Arc Therapy in Three fraction Single-isocenter Stereotactic Radiosurgery for Multiple Brain Metastases. Turk J Oncol 2022;37(1):67–73

   Source : page de profil sur livhospital.com

7. Fayda M, Isin M, Tambas M, Guveli M, Meral R, Altun M, Sahin D, Ozkan G, Sanli Y, Isin H, Ozgur E, Gezer U. Do Circulating Long Non-Coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) Predict the Treatment Response in Patients with Head and Neck Cancer Treated with Chemoradiotherapy? Tumor Biology, 2015, 19 October, DOI: 10.1007/s13277-015-4189-1.

   Source : page de profil sur livhospital.com

8. Fayda M, Tambaş, M, Karanlık H. Is sentinel lymph node biopsy enough for axillary macrometastasis? Turkish Journal of Surgery, 2015, Vol 31(4), pp. 253-255.

   Source : page de profil sur livhospital.com

9. Aydiner A, Sen F, Tambas M, Ciftci R, Eralp Y, Saip P, Karanlik H, Fayda M, Kucucuk S, Onder S, Yavuz E, Muslumanoglu M, Igci A.Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment. Medicine (Baltimore), 2015 Dec;94(52):e2341.

   Source : page de profil sur livhospital.com

10. Karanlık H, Özgür İ, Şahin D, Fayda M, Önder S, Yavuz E. Intraoperative ultrasound reduces the need for re-excision in breast conserving surgery, World Journal of Surgical Oncology, 2015 Nov 24;13(1):321.

    Source : page de profil sur livhospital.com